We are live on ! Find out more
SIP

Stoneridge Investment Partners Portfolio holdings

AUM $152M
1-Year Est. Return 20.58%
This Fund
S&P 500
This Quarter Est. Return
+5.93%
1 Year Est. Return
+20.58%
3 Year Est. Return
+44.17%
5 Year Est. Return
+32.14%
10 Year Est. Return
+92.72%
AUM
$206M
AUM Growth
+$14.9M
Cap. Flow
+$3.9M
Cap. Flow %
1.89%
Top 10 Hldgs %
37.36%
Holding
126
New
21
Increased
23
Reduced
25
Closed
22

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$4.58M
2
DLTR icon
Dollar Tree
DLTR
+$4.42M
3
BAX icon
Baxter International
BAX
+$4.11M
4
TJX icon
TJX Companies
TJX
+$2.39M
5
SBUX icon
Starbucks
SBUX
+$2.33M

Top Sells

Rank Stock Value
1
NKE icon
Nike
NKE
+$4.53M
2
MRK icon
Merck
MRK
+$4.42M
3
WFC icon
Wells Fargo
WFC
+$4.09M
4
DG icon
Dollar General
DG
+$2.97M
5
CVS icon
CVS Health
CVS
+$2.79M

Sector Composition

Rank Sector Weight
1 Technology 26.02%
2 Financials 12.78%
3 Consumer Discretionary 11.96%
4 Communication Services 11.45%
5 Healthcare 10.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WFC icon
76
Wells Fargo
WFC
$265B
$658K 0.32%
14,521
-91,501
-86% -$4.09M
CTSH icon
77
Cognizant
CTSH
$26.3B
$610K 0.3%
8,813
+3,338
+61% +$249K
ALLE icon
78
Allegion
ALLE
$14.1B
$564K 0.27%
4,046
-5,985
-60% -$818K
MLM icon
79
Martin Marietta Materials
MLM
$33B
$563K 0.27%
+1,600
New +$570K
NUE icon
80
Nucor
NUE
$62.5B
$551K 0.27%
5,739
-6,200
-52% -$580K
J icon
81
Jacobs Solutions
J
$17.2B
$532K 0.26%
4,818
REGN icon
82
Regeneron Pharmaceuticals
REGN
$83.2B
$531K 0.26%
+950
New +$481K
ORCL icon
83
Oracle
ORCL
$435B
$514K 0.25%
6,600
-5,850
-47% -$458K
FBIN icon
84
Fortune Brands Innovations
FBIN
$5.73B
$442K 0.22%
5,192
VRTX icon
85
Vertex Pharmaceuticals
VRTX
$133B
$441K 0.21%
2,188
EOG icon
86
EOG Resources
EOG
$74.6B
$431K 0.21%
+5,165
New +$409K
EVRG icon
87
Evergy
EVRG
$18.9B
$369K 0.18%
+6,100
New +$382K
PWR icon
88
Quanta Services
PWR
$99.4B
$315K 0.15%
3,475
FANG icon
89
Diamondback Energy
FANG
$55.7B
$290K 0.14%
3,088
APA icon
90
APA Corp
APA
$14.4B
$275K 0.13%
+12,700
New +$261K
COHR icon
91
Coherent
COHR
$63.6B
$275K 0.13%
3,787
FDX icon
92
FedEx
FDX
$76.9B
$268K 0.13%
897
NTR icon
93
Nutrien
NTR
$31.6B
$267K 0.13%
4,400
CTVA icon
94
Corteva
CTVA
$51B
$254K 0.12%
5,725
-12,625
-69% -$583K
QRVO icon
95
Qorvo
QRVO
$8.56B
$242K 0.12%
1,238
BMRN icon
96
BioMarin Pharmaceuticals
BMRN
$13.3B
$231K 0.11%
2,766
-3,100
-53% -$246K
MPT
97
Medical Properties Trust
MPT
$2.48B
$230K 0.11%
+11,460
New +$245K
PRIM icon
98
Primoris Services
PRIM
$4.35B
$223K 0.11%
7,583
UCTT
99
Ultra Clean Holdings
UCTT
$3.72B
$215K 0.1%
+3,995
New +$214K
MCF
100
DELISTED
Contango Oil & Gas Co.
MCF
$124K 0.06%
+28,811
New +$121K

Similar funds

Stoneridge Investment Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Stoneridge Investment Partners held 126 positions worth $206M, up 7.8% from $191M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Stoneridge Investment Partners's Q2 2021 filing shows 21 new, 23 increased, 25 reduced and 22 closed positions. Its largest new stake was Dollar Tree: 40,692 shares worth $4.05M. The largest sale was Nike, an estimated $4.53M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Stoneridge Investment Partners's largest Q2 2021 buy was Dollar Tree: 40,692 shares worth $4.05M.
  • Stoneridge Investment Partners added most to Zimmer Biomet in Q2 2021, an estimated $4.58M increase.
  • Stoneridge Investment Partners's biggest Q2 2021 reduction was Nike, cutting an estimated $4.53M.
  • Stoneridge Investment Partners fully exited Merck in Q2 2021, selling an estimated $4.42M.
  • Stoneridge Investment Partners's ten largest holdings make up 37% of its $206M portfolio in Q2 2021.
  • Stoneridge Investment Partners opened 21 new positions and closed 22 in Q2 2021.
  • Stoneridge Investment Partners's portfolio value rose 7.8% quarter-over-quarter to $206M.

Based on Stoneridge Investment Partners's 13F filing for Q2 2021, filed 4 Aug 2021.